Abstract
Due to compromised immunity and weakened defense function in patients with AIDS, opportunistic infections commonly occur. Nearly 80 % patients suffering from AIDS die from opportunistic infections. The pathogens causing opportunistic infections include the following four types: viruses, bacteria, fungi and parasites.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Extended Reading
Autran B et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997;277(5322):112–6.
Autran B et al. Restoration of the immune system with anti-retroviral therapy. Immunol Lett. 1999;66(1–3):207–11.
Bishop LR, Kovacs JA. Quantitation of anti-Pneumocystis jiroveci antibodies in healthy persons and immunocompromised patients. J Infect Dis. 2003;187(12):1844–8.
Bogdan C. The function of type I interferons in antimicrobial immunity. Curr Opin Immunol. 2000;12(4):419–24.
Borrow P et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 2001;68(9):6103–10.
Church JD et al. Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants. AIDS Res Hum Retroviruses. 2009;25(7):657–63.
Cooper DA et al. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion Lancet. 1985;1(8428):537–40.
De Paoli P et al. Changes in thymic function in HIV-positive patients treated with highly active antiretroviral therapy and inter leukin-2. Clin Exp Immunol. 2001;125(3):440–6.
Dean M et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996;273(5283):1856–62.
Descamps D et al. Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis. J Clin Microbiol. 1998;36(7):2143–5.
Drmanac S et al. Accurate sequencing by hybridization for DNA diagnostics and individual genomics. Nat Biotechnol. 1998;16(1):54–8.
Emile D et al. Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease and in the development of B lymphomas. Immunol Rev. 1944;140:5–34.
Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science. 1993;262(5136):1011–8.
Feng Y et al. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;272(5263):872–7.
Gupta KK. Acute immunosuppression with HIV seroconversion. N Engl J Med. 1993;328(4):288–9.
Haynes BF et al. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol. 1966;118:529–60.
Kellam P, Larder BA. Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates. Antimicrob Agents Chemother. 1994;38(1):23–30.
Lichterfeld M et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med. 2004;6:701–12.
Liu Y et al. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med. 2000;6(12):1380–7.
Mikovits JA et al. IL-4 and IL-13 have overlapping but distinct effects on HIV production in monocytes. J Leukoc Biol. 1994;56(3):340–6.
Oravecz T, Pall M, Norcross MA. Beta-chemokine inhibition of monocytotropic HIV-1 infection. Interference with a postbinding fusion step J Immunol. 1996;157(4):1329–32.
Petropoulos CJ et al. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2000;44(4):920–8.
Poli G, Fauci AS. The role of monocyte/macrophages and cytokines in the pathogenesis of HIV infection. Pathobiology. 1992;60(4):246–51.
Schacker TW et al. Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest. 2002;110(8):1133–9.
Si-Mohamed A et al. Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. J Infect Dis. 2000;182(1):112–22.
Skelly M et al. S-adenosylmethionine concentrations in diagnosis of Pneumocystis carinii pneumonia. Lancet. 2003;361(93650):1267–8.
Vahey M et al. Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms. J Clin Microbiol. 1999;37(8):2533–7.
Venturi G et al. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. J Infect Dis. 2000;181(2):740–5.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht and People’s Medical Publishing House
About this chapter
Cite this chapter
Li, H. (2014). An Overview of Clinical Microbiology of HIV/AIDS. In: Li, H. (eds) Radiology of HIV/AIDS. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7823-8_3
Download citation
DOI: https://doi.org/10.1007/978-94-007-7823-8_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7822-1
Online ISBN: 978-94-007-7823-8
eBook Packages: MedicineMedicine (R0)